1,7-phenanthroline has been researched along with 5-hydroxytryptophan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danno, T; Fukushima, T; Shimomura, K | 1 |
| D'Alessandro, F; EcheverrÃa, GA; Ferrer, EG; MartÃnez Medina, JJ; Naso, LG; Piro, OE; Rey, M; Rizzi, A; Williams, PAM | 1 |
2 other study(ies) available for 1,7-phenanthroline and 5-hydroxytryptophan
| Article | Year |
|---|---|
An improved method for the determination of exogenous 5-hydroxytryptophan in plasma.
Topics: 5-Hydroxytryptophan; Animals; Brain Chemistry; Cysteine; Fluorometry; Iron; Methods; Phenanthrolines; Rats | 1975 |
Ternary copper(II) complex of 5-hydroxytryptophan and 1,10-phenanthroline with several pharmacological properties and an adequate safety profile.
Topics: 5-Hydroxytryptophan; A549 Cells; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Artemia; Cell Movement; Cell Proliferation; Coordination Complexes; Copper; Humans; Lung Neoplasms; Phenanthrolines; Toxicity Tests | 2020 |